Pricing Integrative Oncology Services: What the Market Tells Us and How to Build a Sustainable Model

Pricing Integrative Oncology Services:

What the Market Tells Us and How to Build a Sustainable Model

Business Insights for the Modern Integrative Physician

Pricing Integrative Oncology Services:

What the Market Tells Us and How to Build a Sustainable Model

Yoon Hang Kim, MD, MPH

Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician

Founder, Direct Integrative Care

Introduction: The Unpriced Gap in Oncology Care

Cancer patients want more than tumor shrinkage. They want to understand why their body became hospitable to cancer, what they can do to support their treatment, how to minimize side effects, and how to reduce the risk of recurrence. Conventional oncology — brilliant at cutting, burning, and drugging tumors — is largely silent on these questions. The visit is 15 minutes. The agenda is the next scan.

That gap is both a clinical problem and a business opportunity. Integrative oncology exists to fill it. And for physicians with the training, experience, and patience to do this work well, building a sustainable integrative oncology practice is not only possible — it is increasingly necessary as patient demand grows and the limitations of conventional care become more apparent.

This article examines the real-world economics of physician (MD)-delivered integrative oncology services: what peers are charging, what structures are working, and how to think about your own pricing in a way that honors your expertise while remaining patient-accessible.

A Note on Scope

This analysis focuses specifically on MD-delivered integrative oncology services — not naturopathic oncology, academic integrative cancer programs, or hospital-based programs that carry different cost structures. While ND-delivered integrative oncology fills an important role, the pricing dynamics, scope of practice, and patient expectations differ meaningfully from MD-level services.

The Real-World MD Integrative Oncology Market

Surveying cash-pay MD integrative oncology practices across the United States reveals a relatively consistent pricing band. Several representative programs illustrate the range:

Table 1. Representative MD integrative oncology cash prices (US, 2024–2025)

Several patterns emerge from this data:

• A 60–90-minute MD integrative oncology initial consultation typically falls between $500 and $800, with the mean around $650–$750.
• Follow-up visits of 60 minutes are commonly priced at 40–70% of the initial fee, generally $350–$600.
• High-touch Austin-area MD integrative models can reach $1,200 for extended 90–120-minute intakes with substantial case review and written protocol delivery.
• Telehealth-only integrative practices tend to price at the lower end of the range ($350–$595), reflecting lower overhead and a broader geographic draw.
• Brief follow-up visits of 15–30 minutes typically run $100–$250, often structured as incremental time-based billing.

For context, a conventional oncologist visit in Texas averages $93–$139 in cash price. The integrative oncology premium — 5 to 8 times the conventional rate — reflects time, scope, and the depth of individualized clinical work involved.

Why Integrative Oncology Commands a Premium

The pricing differential is not arbitrary. It reflects the structural difference in what is actually delivered during an integrative oncology consultation:

Time

Where a conventional oncology follow-up might run 10–15 minutes, a meaningful integrative oncology consultation requires 60–90 minutes at minimum. Tumor boards take 30 minutes per case. An integrative oncology visit — reviewing labs, functional status, supplements, drug interactions, nutritional status, stress physiology, sleep, and lifestyle — takes at least as long.

Cognitive Load

Integrative oncology requires fluency across multiple clinical domains simultaneously: pharmacognosy and supplement-drug interactions, functional lab interpretation, nutritional biochemistry, mind-body research, psycho-oncology, and conventional oncology protocols. The cognitive overhead per case is substantial.

Pre-Visit and Post-Visit Work

Many integrative oncology physicians invest significant time before and after the visit — reviewing prior records, conventional treatment plans, labs, imaging reports, and pathology; researching specific tumor types and emerging integrative evidence; and preparing written protocols and summaries that patients can actually use.

Scope of the Written Plan

A well-delivered integrative oncology consultation does not end with a verbal discussion. It produces something: a documented protocol covering nutrition, targeted supplementation, lifestyle modifications, mind-body practices, and coordination recommendations for the conventional oncology team. That deliverable has time value.

Patients who understand what they are actually receiving — and who have experienced the contrast of a 12-minute conventional oncology visit — generally regard $700–$800 for a comprehensive 75–90-minute integrative oncology consultation as entirely reasonable.

Building a Pricing Architecture That Works

The most sustainable MD integrative oncology practices tend to use a layered pricing structure rather than a single per-visit fee. Here is a framework worth considering:

Layer 1: Non-Member Extended Consultation

This is the entry point for patients who are not yet ready to commit to an ongoing relationship. A single extended consultation — initial or follow-up — priced consistently regardless of whether it is the first or a subsequent visit creates simplicity and positions your time as uniformly valuable.

A rate in the $700–$800 range for a 75–90-minute MD integrative oncology consultation aligns with peer pricing at MindStream and Spring Trail, and is well-supported by the market data. Some practices, including our own, have settled on a flat $750 per extended consultation for non-members, whether initial or follow-up, to simplify the patient-facing message.

For truly micro-interactions — a quick question, a portal message review, a brief call — a per-minute billing model (e.g., $10/minute with a 1-minute minimum) is an effective way to make your time available without undervaluing it or opening an unlimited texting relationship with non-members. At that rate, a 5-minute reply is $50; a 15-minute phone discussion is $150 — rates that gently incentivize patients to join a membership structure.

Layer 2: Membership Model

For patients who need ongoing care — and most integrative oncology patients do — a monthly membership is the most patient-friendly and practice-sustainable structure. Membership can include a defined number of visits, unlimited messaging within a reasonable scope, priority scheduling, and direct access to the physician.

Monthly membership fees in the $200–$500 range are common for integrative medicine practices. At $300 per month, a patient who engages regularly receives substantial value relative to the $750/visit non-member rate, creating a clear incentive to join without devaluing the non-member rate.

The math is instructive: a patient paying $300/month for 12 months spends $3,600 annually. Two non-member visits at $750 each is $1,500. Membership becomes the clear winner for any patient who needs more than two meaningful touchpoints per year — which is essentially every active integrative oncology patient.

Layer 3: Bundled Programs

Some practices offer defined multi-month integrative oncology programs for patients undergoing active treatment — chemotherapy, radiation, surgery — where intensive support is needed for a defined period. Published program fees in this category range from $3,000 to $8,000 for comprehensive multi-month engagements that include frequent visits, protocol design, and ongoing oversight.

A bundled program works well when the scope is clearly defined, the duration is finite, and the deliverables are explicit. It also aligns physician incentive with patient outcomes rather than creating fee-per-encounter pressure during an already difficult treatment period.

The Membership Advantage: Vision Over Volume

There is a broader argument for the membership model that goes beyond pricing strategy. Integrative oncology — done well — requires a relationship, not a transaction. Tumor biology evolves. Treatment plans change. Patients have crises at 10 PM on a Tuesday. Conventional oncology handles this through a triage network; integrative oncology physicians working in small practices are often the most trusted person in the patient's care ecosystem.

A membership model creates the structural conditions for that kind of relationship to exist. It guarantees access. It rewards continuity. It caps your panel at a size you can actually serve well, rather than generating volume pressure that degrades the quality of care.

Practices deliberately capped at small panels — 60 to 100 patients — allow the physician to know every patient's case deeply, respond meaningfully when things change, and function as a true integrative partner rather than a supplement consultant who sees patients four times a year and re-reads the chart each time.

This is a fundamentally different business model than the fee-for-service volume treadmill. It is also, for most integrative oncology physicians who entered this field because they genuinely want to help patients at depth, a far more sustainable and satisfying way to practice.

What the Numbers Mean for Your Practice

Let's make this concrete. Consider a membership-based integrative oncology practice with:

• Panel size: 60 active members
• Monthly membership fee: $300/month
• Projected non-member consultations: 4–6 per month at $750 each
• Minimal overhead (telemedicine or hybrid with shared space)

At steady state, membership revenue alone is $18,000/month ($216,000/year) from 60 patients. Adding 5 non-member consultations per month at $750 adds $4,500/month ($54,000/year). Gross annual revenue: approximately $270,000 from a panel of 60 patients, with overhead that is a fraction of a conventional clinic.

This is not a high-volume model. It is a high-value model — and it is viable precisely because integrative oncology commands the premium it earns.

Compare this to the alternative: an insurance-based practice seeing 20–25 patients per day, fighting for reimbursements, spending 30% of revenue on billing administration, and delivering 12-minute visits that satisfy no one. The economics of the integrative oncology membership model are not just better for the patient — they are better for the physician.

Pricing Objections and How to Think About Them

'My patients can't afford this.'

Some cannot. That is real. But integrative oncology patients are often people who have already spent tens of thousands of dollars on conventional cancer treatment, some of which was extraordinarily uncomfortable and only partially effective. A patient who spends $300/month for deep, personalized, relationship-based integrative support is spending less than most cable-and-streaming packages — and receiving something that may meaningfully affect their outcomes and quality of life.

The appropriate response to the affordability concern is not to underprice your services to the point of unsustainability. It is to be thoughtful about your sliding scale policy, to offer a few membership spots at reduced fees for patients in genuine financial hardship, and to be transparent about what you can and cannot offer.

'Other practices charge less.'

Some do. What they also often do is see more patients than they can serve well, burn out faster, and eventually reduce the depth of engagement that made their work valuable in the first place. Pricing below market is not inherently virtuous; it is often just a slower path to the same compromises.

Your pricing should reflect your training, your time, the depth of your engagement, and the sustainability of your practice. If you price your work at $750 for a 75–90-minute MD integrative oncology consultation, you are pricing it at the market rate for MD integrative oncology. That is not gouging; that is pricing.

'I feel uncomfortable charging what I'm worth.'

Many physicians do. This is worth examining directly. Integrative medicine attracts people who are motivated by service, and there is a cultural tendency in medicine to conflate high fees with greed. But an unsustainably priced practice that closes in two years helps no one. A well-priced practice that is still serving patients in ten years — with the physician still engaged, still curious, still growing — is a better outcome for everyone.

You cannot practice integrative oncology from burnout.

Conclusion: Pricing as a Clinical Decision

How you price your services is not just a business decision. It is a clinical one. Your pricing structure determines how many patients you can see, how deeply you can engage with each one, how much time you have to stay current with the evidence, and whether the practice is sustainable enough to be there when your patients need it most.

The market data is clear: MD integrative oncology consultations of 75–90 minutes command $700–$800 in cash-pay markets across the country. Membership-based models at $250–$400/month create sustainable ongoing relationships. Layered pricing structures — with a defined non-member rate and a compelling membership option — communicate value clearly and give patients a sensible path toward deeper engagement.

For physicians who have invested years in developing genuine integrative oncology expertise — the knowledge of herb-drug interactions, tumor biology, functional medicine frameworks, and the art of meeting a frightened patient in a moment of serious illness — pricing that work appropriately is not uncomfortable. It is the foundation of a practice that can actually do good.

About Dr. Kim

Yoon Hang Kim, MD, MPH is a board-certified Preventive Medicine physician and Integrative & Functional Medicine practitioner with over 20 years of clinical experience. He completed fellowship training at the University of Arizona Andrew Weil Center for Integrative Medicine and holds certifications in preventive medicine, acupuncture, and integrative/holistic medicine. Dr. Kim specializes in low-dose naltrexone (LDN), autoimmune conditions, chronic pain, integrative oncology, fibromyalgia, chronic fatigue syndrome, mast cell activation syndrome (MCAS), and mold toxicity. He is the author of three books and more than 20 articles on LDN and integrative medicine.

Professional: www.yoonhangkim.com   |   Clinical: www.directintegrativecare.com